Be able to understand and evaluate a scientific article relating to a cost-effectiveness analysis and/or a HTA (Health Technology Assessment) as a whole.
Understand the context and rationale of HTA in general and economic evaluation in particular (the WHY). Acquire the key analytical concepts used in economic evaluation applied to health technologies (the HOW).
Analysis of a number of scientific articles.
Lessons ex cathedra and short presentation prepared by the students, analysis of scientific articles
An exhaustive list of questions for the exam is elaborate enduring the course
The exact modalities of the evaluation are likely to be modified during the preparation of the examination schedules, depending on the practical constraints with which the faculty administration may be confronted, or in the event of illness / force majeure / encroachment with an internship.
Powerpoint
Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Threshold values for cost-effectiveness in health care Health Technology Assessment (HTA).
Brussels: Belgian Health Care Knowledge Centre (KCE); 2008. KCE reports 100C (D/2008/10.273/96)
Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses: second edition. Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE). 2012. KCE Report 183C. D/2012/10.273/54
Recent articles concerning an HTA
| Training | Study programme | Block | Credits | Mandatory |
|---|---|---|---|---|
| Master in Biomedical Sciences, Professional focus in Clinical Research | Standard | 0 | 2 | |
| Master in Biomedical Sciences | Standard | 0 | 2 | |
| Master in Biomedical Sciences, Professional focus in Preclinical Research | Standard | 0 | 2 | |
| Master in Biomedical Sciences | Standard | 1 | 2 | |
| Master in Biomedical Sciences, Professional focus in Preclinical Research | Standard | 2 | 2 | |
| Master in Biomedical Sciences, Professional focus in Clinical Research | Standard | 2 | 2 |